[Intravesical oxybutynin in children with meningomyelocele. Efficient treatment with few side-effects].
Von Zweigbergk
M
M
Barn- och ungdomsmedicinska kliniken, Norrlands Universitetssjukhus, Umeå.
Nordin
B
B
Jonsson
S
S
D000283:Administration, Intravesical; D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D018680:Cholinergic Antagonists / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D008333:Mandelic Acids / Q000008:administration & dosage* / Q000009:adverse effects; D008591:Meningomyelocele / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D010276:Parasympatholytics / Q000008:administration & dosage* / Q000009:adverse effects; D001743:Urinary Bladder / Q000187:drug effects* / Q000503:physiopathology; D001750:Urinary Bladder, Neurogenic / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology
D018680:Cholinergic Antagonists; D008333:Mandelic Acids; D010276:Parasympatholytics; C005419:oxybutynin
Oxybutynin intravesikalt på barn med ryggmärgsbråck. Effektiv behandling med få biverkningar.